4.7 Article

Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Fidaxomicin: A Macrocyclic Antibiotic for the Management of Clostridium difficile Infection

Karyn M. Sullivan et al.

ANNALS OF PHARMACOTHERAPY (2010)

Editorial Material Medicine, General & Internal

Clostridium difficile - Beyond Antibiotics

Lorraine Kyne

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, General & Internal

Treatment with Monoclonal Antibodies against Clostridium difficile Toxins

Israel Lowy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Infectious Diseases

Novel biaryl oxazolidinones: in vitro and in vivo activities with pharmacokinetics in an animal model

Tarani Kanta Barman et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)

Article Medicine, General & Internal

Clostridium difficile Colitis

Janet M. Torpy

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Infectious Diseases

Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria

Diane M. Citron et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)

Article Multidisciplinary Sciences

Toxin B is essential for virulence of Clostridium difficile

Dena Lyras et al.

NATURE (2009)

Article Infectious Diseases

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

Simon D. Baines et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)

Article Public, Environmental & Occupational Health

Costs of nosocomial Clostridium difficile-associated diarrhoea

R. -P. Vonberg et al.

JOURNAL OF HOSPITAL INFECTION (2008)

Article Medicine, General & Internal

Clostridium difficile— More Difficult Than Ever

Ciarán P. Kelly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Gastroenterology & Hepatology

Review article: tolevamer, a novel toxin-binding polymer: overview of preclinical pharmacology and physicochemical properties

R. H. Barker et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)

Review Medicine, General & Internal

Clostridium difficile associated diarrhoea:: diagnosis and treatment

J Starr

BMJ-BRITISH MEDICAL JOURNAL (2005)

Review Medicine, General & Internal

Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea:: a systematic review

N Dendukuri et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)

Letter Infectious Diseases

In vitro activity of linezolid against Clostridium difficile

G Ackermann et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)

Article Gastroenterology & Hepatology

Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease

LV McFarland et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)

Article Microbiology

In vitro activity of linezolid against Clostridium difficile

T Paláez et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)

Article Biotechnology & Applied Microbiology

A rapid staining technique for the detection of the initiation of germination of bacterial spores

T Hamouda et al.

LETTERS IN APPLIED MICROBIOLOGY (2002)

Article Immunology

Infection of hamsters with epidemiologically important strains of Clostridium difficile

SP Sambol et al.

JOURNAL OF INFECTIOUS DISEASES (2001)

Review Medicine, General & Internal

Clostridium difficile-associated diarrhea -: A review

E Mylonakis et al.

ARCHIVES OF INTERNAL MEDICINE (2001)

Article Microbiology

In vitro and in vivo activities of nitazoxanide against Clostridium difficile

CS McVay et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)